India’s drugs regulator has issued "show cause" notices and could soon blacklist eight major Chinese pharmaceutical firms found to be supplying poor quality raw materials.
The Central Drug Standards Control Organisation (CDSCO) issued the notices after a special inspection team on behalf of the Drug Controller General of India (DCGI) inspected the eight companies in China in November.
☛ Want to stay up to date with the news? Sign up to our daily bulletin.